Cost impact of a non-invasive, portable device for patient self-administration of chronic migraine in a UK National Health Service setting

BACKGROUND: Chronic migraine (CM) is a neurological disorder associated with substantial disability. Botulinum toxin type A (Botox) is an approved and effective preventive treatment option for adult patients with CM. Transcranial magnetic stimulation (TMS) is an alternative treatment device deliveri...

Descripción completa

Detalles Bibliográficos
Autores principales: Brüggenjürgen, B., Baker, T., Bhogal, R., Ahmed, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972802/
https://www.ncbi.nlm.nih.gov/pubmed/27536532
http://dx.doi.org/10.1186/s40064-016-2924-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972802/
https://www.ncbi.nlm.nih.gov/pubmed/27536532
http://dx.doi.org/10.1186/s40064-016-2924-8

Ejemplares similares